Australia's most trusted
source of pharma news
Posted 23 June 2026 PM
The ASCO Breakthrough Conference is kicking off in Singapore for the first time this week, with attendees hearing about the personalisation of public health systems and adapting treatments to the region.
Cohosted by the American Society of Clinical Oncology (ASCO) and the Singapore Society of Oncology (SSO), the keynote lectures will address ways to personalise oncology treatment, including one by University of Cambridge Professor of the Epidemiology of Aging, Dr Nora Pashayan, titled Can Precision Medicine Be Applied to Public Health?

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.